Experts highlight myositis-specific and associated autoantibody (MSA/MAA) testing in diagnosing idiopathic inflammatory myopathy
Etanercept tapering is feasible without compromising the efficacy in patients with autoimmune disease
Anti–IL-1 receptor antagonist autoantibodies stimulate inflammatory and fibrotic mediators in IgG4-related disease
Human leukocyte antigen-B27 status is not suggestive of treatment response in psoriatic arthritis axial disease
Peripheral blood NLR and LMR may assist in predicting renal function and prognosis in patients with lupus nephritis
